Clinical Trial Update: A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)

View source ↗

Summary

The MASTER-2 trial in relapsing multiple sclerosis, evaluating suboptimally controlled participants previously on oral or infusion disease-modifying therapies, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Multiple Sclerosis | Status: COMPLETED | Results posted: 2026-01-02